Herbal hepatotoxicity: current status, examples, and challenges

Bibliography

• Ingawale DK, Mandlik SK, Naik SR. Models of hepatotoxicity and the underlying cellular, biochemical and immunological mechanism(s): A critical discussion. Environ Toxicol Pharmacol 2014;37:118-33
   PubMed Web of Science ®Google Scholar
• Schjøtt J. Adverse effects of drugs and toxins on the liver. In: Mizuguchi Y, editor. Liver biopsy in modern medicine. InTech; Rijeka, Croatia. 2011; p 137-62
   Google Scholar
• Ifeoma O, Oluwakanyinsola S. Screening of herbal medicines for potential toxicities. Gowder S, editor. New insights into toxicity and drug testing. InTech; Rijeka, Croatia. 2013; p 63-88
   Google Scholar
• Willett KL, Roth RA, Walker L. Workshop overview: Hepatotoxicity assessment for botanical dietary supplements. Toxicol Sci 2004;79:4-9
   PubMed Web of Science ®Google Scholar
• Moreira DL, Teixeira SS, Monteiro MHD, et al. Traditional use and safety of herbal medicines. Brazilian J Pharmacognosy 2014;24:248-57
   Web of Science ®Google Scholar
• Larrey D, Faure S. Herbal medicine hepatotoxicity: A new step with development of specific biomarkers. J Hepatol 2011;26:599-601
   Web of Science ®Google Scholar
• Larrey D. Hepatotoxicity of herbal remedies. J Hepatol 1997;26:47-51
   PubMedGoogle Scholar
• Chen L, Zhang F, Kong D, et al. Saikosaponin D disrupts platelet-derived growth factor-b receptor/p38 pathway leading to mitochondrial apoptosis in human LO2 hepatocyte cells: A potential mechanism of hepatotoxicity. Chem-Biol Interact 2013;206:76-82
   PubMed Web of Science ®Google Scholar
• Wang J, Zhao H, Zhao Y, et al. Hepatotoxicity or hepatoprotection? Pattern recognition for the paradoxical effect of the Chinese herb Rheum palmatum L. in treating rat liver injury. PLoS One 2011;6:1-8
   Web of Science ®Google Scholar
• Teschke R, Eickhoff A. Herbal hepatotoxicity in traditional and modern medicine; actual key issues and new encouraging steps. Front Pharmacol 2015;6:72
   PubMed Web of Science ®Google Scholar
• Teschke R, Frenzel C, Schulze J, Eickhoff A. Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World J Gastroenterol 2013;19:2864-82
   PubMed Web of Science ®Google Scholar
• Bunchorntavakul C, Reddy KR. Review article: herbal and dietary supplement hepatotoxicity. Aliment Pharmacol Ther 2013;37:3-17
   PubMed Web of Science ®Google Scholar
• Reynolds T, Dweck AC. Aloe vera gel: a review update. J Ethnopharmacol 1999;68:3-37
   PubMed Web of Science ®Google Scholar
• Van Wyk BE, Smith G. Guide to the Aloes of South Africa. 2nd edition. Briza; Pretoria: 2005
   Google Scholar
• Grace OM, Dzajiv A, Jäger A, et al. Monosaccharide analysis of succulent leaf tissue in Aloe. Phytochemistry 2013;93:79-87
   PubMed Web of Science ®Google Scholar
• Jia Y, Zhao G, Jia J. Preliminary evaluation: The effects of Aloe ferox Miller and Aloe arborescens Miller on wound healing. J Ethnopharmacol 2008;120:181-9
   PubMed Web of Science ®Google Scholar
• Tanaka M, Misawa E, Ito Y, et al. Identification of five phytosterols from Aloe vera gel as anti-diabetic compounds. Biol Pharm Bull 2006;29:1418-22
   PubMed Web of Science ®Google Scholar
• Chithra P, Sajithlal GB, Chandrakasan G. Influence of Aloe vera on the healing of dermal wounds in diabetic rats. J Ethnopharmacol 1998;59:195-201
   PubMed Web of Science ®Google Scholar
• Koo MWL. Aloe vera: antiulcer and antidiabetic effects. Phytother Res 1994;8:461-4
   Web of Science ®Google Scholar
• Saito H. Purification of active substances of Aloe arborescens Miller and their biological and pharmacological activity. Phytother Res 1993;7:S14-19
   Web of Science ®Google Scholar
• Hamman JH. Composition and applications of Aloe vera leaf gel. Molecules 2008;13:1599-16
   PubMed Web of Science ®Google Scholar
• Harlev E, Nevo E, Lansky EP, et al. Anticancer potential of aloes: antioxidant, antiproliferative and immunostimulatory attributes. Planta Med 2012;78:843-52
   PubMed Web of Science ®Google Scholar
• Boudreau MD, Beland FA. An evaluation of the biological and toxicological properties of Aloe barbadensis (Miller) Aloe vera. J Environ Sci Health Part C 2006;24:103-54
   Web of Science ®Google Scholar
• Rabe C, Musch A, Schirmacher P, et al. Acute hepatitis induced by an Aloe vera preparation: A case report. World J Gastroenterol 2005;11:303-4
   PubMed Web of Science ®Google Scholar
• Kanat O, Ozet A, Ataergin S. Aloe vera-induced toxic hepatitis in a healthy young man. Eur J Internal Med 2006;17:589
   PubMed Web of Science ®Google Scholar
• Bottenberg MM, Wall GC, Harvey RL, et al. Oral Aloe vera-induced hepatitis. Ann Pharmacother 2007;41:1740-3
   PubMed Web of Science ®Google Scholar
• Yang HN, Kim DJ, Kim YM, et al. Aloe-induced toxic hepatitis. J Koeran Med Sci 2010;25:492-5
   PubMed Web of Science ®Google Scholar
• Lee J, Lee MS, Nam KW. Acute toxic hepatitis caused by an Aloe vera preparation in a young patient: A case report with a literature review. Korean J Gastroenterol 2014;64:54-8
   PubMedGoogle Scholar
• Kwack SJ, Kim KB, Lee BM. Estimation of tolerable upper intake level of active Aloe. J Toxicol Environ Health 2009;72:21-2
   Google Scholar
• Lynch B, Simon R, Roberts A. In vitro and in vivo assessment of the genotoxic activity of aloesin. Reg Toxicol Pharmacol 2011;61:215-21
   PubMed Web of Science ®Google Scholar
• Can A, Akev N, Ozsoy N, et al. Effect of Aloe vera leaf gel and pulp extracts on the liver in type-II diabetic rat models. Biol Pharm Bull 2004;27:694-8
   PubMed Web of Science ®Google Scholar
• Cui Y, Ye Q, Wang H, et al. Hepatoprotective potential of Aloe vera polysaccharides against chronic alcohol-induced hepatoxicity in mice. J Sci Food Agric 2014;94:1764-71
   PubMed Web of Science ®Google Scholar
• Saka WA, Akhigbe RE, Ishola OS, et al. Hepatotherapeutic effect of Aloe vera in alcohol induced hepatic damage. Pak J Biol Sci 2011;15:742-6
   Google Scholar
• Chandan BK, Saxena AK, Shukla S, et al. Hepatoprotective potential of Aloe barbadensis Mill. against carbon tetrachloride induced hepatotoxicity. J Enthnopharmacol 2007;111:560-6
   PubMed Web of Science ®Google Scholar
• Kim S-H, Cheon HJ, Yun N, et al. Protective effect of a mixture of Aloe vera and Silybum marianum against carbon tetrachloride-induced acute hepatotoxicity and liver fibrosis. J Pharmacol Sci 2009;109:119-27
   PubMed Web of Science ®Google Scholar
• Norikura T, Kennedy DO, Nyarko AK, et al. Protective effect of aloe extract against the cytotoxicity of 1,4 naphtoquinone in isolated rat hepatocytes involves modulation in cellular thiol levels. Pharmaco Toxicol 2002;90:278-84
   PubMedGoogle Scholar
• Barnes J, Anderson LA, Phillipson JD. Herbal medicines. 13th edition. Pharmaceutical Press; London: 2007
   Google Scholar
• Johson TL, Fahey JW. Black cohosh: coming full circle? J Ethnopharmacol 2012;141:775-9
   PubMed Web of Science ®Google Scholar
• Small CJ, Chamberlain JL, Mathews DS. Recovery of black cohosh (Actaea racemosa L.) following experimental harvests. Am Midl Nat 2011;166:339-48
   Web of Science ®Google Scholar
• Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa): a systematic review of adverse events. Am J Obstet Gynecol 2008;199:455-66
   PubMed Web of Science ®Google Scholar
• Einbond LS, Soffritti M, Espoti DD, et al. Pharmacological mechanisms of black cohosh in Sprague-Dawley rats. Fitoterapia 2012;83:461-8
   PubMed Web of Science ®Google Scholar
• Mercado-Feliciano M, Cora MC, Witt KL, et al. An ethanolic extract of black cohosh causes hematological changes but not estrogenic effects in rats. Toxicol Appl Pharm 2012;263:138-47
   PubMed Web of Science ®Google Scholar
• Huntley A, Ernst E. A systematic review of the safety of black cohosh. Menopause 2003;10:58-64
   PubMed Web of Science ®Google Scholar
• Lynch CR, Folkers ME, Hutson WR. Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transplant 2006;12:989-22
   PubMed Web of Science ®Google Scholar
• Guzman G, Kallwitz ER, Wojewoda C, et al. Liver injury with features mimicking autoimmune hepatitis following the use of black cohosh. Case Report Med 2009;2009:1-8
   Google Scholar
• Enbom ET, Le MD, Oesterich L, et al. Mechanism of hepatotoxicity due to black cohosh (Cimicifuga racemosa): histological, immunohistochemical, and electron microscopy analysis of two liver biopsies with clinical correlation. Exp Mol Pathol 2014;96:279-83
   PubMed Web of Science ®Google Scholar
• Teschke R. Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm: a critical review. Menopause 2010;17:426-40
   PubMed Web of Science ®Google Scholar
• Van Auken OW. Shrub invasions of North American semiarid grasslands. Annu Rev Ecol Syst 2000;31:197-15
   Google Scholar
• Whitford WG, Nielson R, De Soyza A. Establishment and effects of creosote bush, Larrea tridentata, on a Chihuahuan Desert watershed. J Arid Environ 2001;47:1-10
   Web of Science ®Google Scholar
• Nellesen J. Larrea tridentata. Oecologia 1997;109:19-27
   Web of Science ®Google Scholar
• Kay M. Healing with Plants in the American and Mexican West. University of Arizona Press; Tucson: 1996. 178-81
   Google Scholar
• Moser M. Seri Indians ethnobotany. Kiva 1970;35:201
   Google Scholar
• Brent J. Three new herbal hepatotoxic syndromes. J Toxicol Clin Toxicol 1999;37:715-19
   PubMed Web of Science ®Google Scholar
• Sheikh N, Philen R, Love L. Chaparral-associated hepatotoxicity. Arch Med Res 1997;157:913-19
   Google Scholar
• Ulbricht C, Basch S, Basch E, et al. Chaparral Monograph: A Clinical Decision Support Tool. J Herbal Pharmacother 2003;3:121-33
   PubMedGoogle Scholar
• Nakadate T, Yamamoto S, Aizu E, et al. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced increase in vascular permeability in mouse skin by lipoxygenase inhibitors. Jpn J Pharmacol 1985;38:161-8
   PubMedGoogle Scholar
• Salari H, Braquet P, Borgeat P. Comparative effects of indomethacin, acetylenicacids, 15- HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prostaglandins Leukot Med 1984;13:53-6
   PubMedGoogle Scholar
• Gimeno MF, Shattner MA, Borda E, et al. Lipoxygenase inhibitors alter aggregation and adhesiveness of human blood platelets from aspirin-treated patients. Prostaglandins Leukot Med 1983;11:109-19
   PubMed Web of Science ®Google Scholar
• Agarwal R, Wang ZY, Bik DP, et al. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated mono-oxygenase activity in rat epidermal and hepatic microsomes. Drug Metab and Disp 1991;19:620-4
   PubMed Web of Science ®Google Scholar
• Drecktrath P, De Figueiredo R, Mason M, et al. Retrograde trafficking of both Golgi complex and TGN markers to the ER induced by NDGA and cyclophenil diphenol. J Cell Sci 1998;111:951-65
   PubMed Web of Science ®Google Scholar
• Safayhi H, Mack J, Sabieraj M, et al. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol ExpTher 1992;261:l143-6
   Google Scholar
• Fujiwara T, Misumi Y, Ikehara Y. Dynamic recycling of ERGIC53 between the endoplasmic reticulum and the Golgi complex is disrupted by nordihydroguaiaretic acid. Biochem Biophys Res 1998;253:869-76
   PubMed Web of Science ®Google Scholar
• Ballatori N, Wang W. Nordihydroguaiaretic acid depletes ATP and inhibits a swelling-activated, ATP-sensitive taurine channel. Am J Physiol 1997;272:C1429-36
   PubMed Web of Science ®Google Scholar
• Fujiwara T, Takami N, Misumi Y, et al. Nordihydroguaiaretic acid blocks protein transport in the secretory pathway causing redistribution of Golgi proteins into the endoplasmic reticulum. J Biol Chem 1998;273:3068-75
   PubMed Web of Science ®Google Scholar
• Stickel F, Seitz HK. The efficacy and safety of comfrey. Public Health Nutr 2000;3:501-8
   PubMed Web of Science ®Google Scholar
• Mei N, Guo L, Fu PP, et al. Metabolism, genotoxicity, and carcinogenicity of comfrey. J Toxicol Environ Health 2010;13:509-26
   Web of Science ®Google Scholar
• Abdualmjid RJ, Sergi C. Hepatotoxic botanicals - an evidence-based systematic review. J Pharm Pharmaceut Sci 2013;16:376-04
   PubMed Web of Science ®Google Scholar
• Guo L, Mei N, Dial S, et al. Comparison of gene expression profiles altered by comfrey and riddelliine in rat liver. BMC Bioinformatics 2007;8:S22
   PubMed Web of Science ®Google Scholar
• Roman GP, Neagu E, Moroeanu V, Radu GL. Concentration of Symphytum officinale extracts with cytostatic activity by tangential flow ultrafiltration. Roumanian Biotech Lett 2008;13(6):4008-13
   Web of Science ®Google Scholar
• Rode D. Comfrey toxicity revisited. TRENDS Pharmacol Sci 2002;23(11):497-9
   PubMed Web of Science ®Google Scholar
• Oberlies NH, Kim N-C, Brine DR, et al. Analysis of herbal teas made from the leaves of comfrey (Symphytum officinale): reduction of N-oxides results in order of magnitude increases in the measurable concentration of pyrrolizidine alkaloids. Public Health Nutr 2004;7(7):919-24
   PubMed Web of Science ®Google Scholar
• Györik S, Stricker H. Severe pulmonary hypertension possibly due to pyrrolizidine alkaloids in polyphytotherapy. Swiss Med Wkly 2009;139(13-14):210-11
   PubMed Web of Science ®Google Scholar
• Rogelj B, Popovič T, Ritonja A, et al. Chelidocystatin, a novel phytostatin from Chelidonium majus. Phytochem 1998;49(6):1645-9
   PubMed Web of Science ®Google Scholar
• Gilca M, Gaman L, Panait E, et al. Chelidonium majus – an integrative review: Traditional knowledge versus modern findings. Forsch Komplementmed 2010;17:241-8
   PubMedGoogle Scholar
• Tomè F, Colombo ML. Distribution of alkaloids in Chelidonium majus and factors affecting their accumulation. Phytochem 1995;40(1):37-9
   Web of Science ®Google Scholar
• Moro PA, Cassetti F, Giugliano G, et al. Hepatitis from Greater celandine (Chelidonium majus L.): Review of literature and report of a new case. J Ethnoparmacol 2009;124:328-32
   PubMed Web of Science ®Google Scholar
• Greving I, Meister V, Monnerjahn C, et al. Chelidonium majus: a rare reason for severe hepatotoxic reaction. Pharmacoepidemiol Drug Safety 1998;7:S66-9
   PubMed Web of Science ®Google Scholar
• Teschke R, Frenzel C, Glass X, et al. Greater Celandine hepatotoxicity: a clinical review. Ann Hepatology 2012;11(6):838-48
   PubMed Web of Science ®Google Scholar
• Mazzanti G, Di Sotto A, Franchitto A, et al. Chelidonium majus is not hepatotoxic in Wistar rats, in a 4 weeks feeding experiment. J Ethnopharmacol 2009;126:518-23
   PubMed Web of Science ®Google Scholar
• Sajilata MG, Bajaj PR, Singhal RS. Tea Polyphenols as Nutraceuticals. Compr. Rev. Food Sci. Food Safety 2008;7:229-54
   Web of Science ®Google Scholar
• Harbowy ME, Balentine DA, Davies AP, et al. Tea Chemistry. Crit Rev Plant Sci 1997;16:415-80
   Web of Science ®Google Scholar
• Joubert E, Muller CJF, De Beer D, et al. The potential role of phenolic acids in tea and herbal teas in modulating effects of obesity and diabetes. Munne-Bosch S, editor. Phenolic acids: composition, applications and health benefits. Nova Science Publishers, Inc; New York: 2012; ISBN: 978-1-61942-032-82011
   Google Scholar
• Tang W, Li S, Liu Y, et al. Anti-diabetic activity of chemically profiled green tea and black tea extracts in a type 2 diabetes mice model via different mechanisms J Funct Foods. 2013;5(4):1784-93
   Google Scholar
• Sano MY, Takahashi K, Yoshino K, et al. Effect of tea (Camellia Sinensis L.) on lipid peroxidation in rat liver and kidney: A comparison of green and black tea feeding. Biol Pharm Bull 1995;18:1006-8
   PubMed Web of Science ®Google Scholar
• Balouchzadeh A, Rahimi HR, Ebadollahi-Natanzi AR, et al. Aqueous Extract of Iranian Green Tea Prevents Lipid Peroxidation and Chronic Ethanol Liver Toxicity in Rat. J Pharmacol Toxicol 2011;6:691-700
   Google Scholar
• Bharali M, Chetry L. Hepatoprotective role of green tea extract in acetaminophen induced liver injury in mice. SAJEB. 2013. Available from: http://sajeb.org/index.php/sajeb/article/view/16649 [Last accessed 30 March 2015]
   Google Scholar
• Chantre P, Lairon D. Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine 2002;9:3-8
   PubMed Web of Science ®Google Scholar
• Dulloo AG, Duret C, Rohrer D, et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr 1999;70:1040-5
   PubMed Web of Science ®Google Scholar
• Lambert JD, Elias RJ. The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention. Arch Biochem Biophys 2010;501:65-72
   PubMed Web of Science ®Google Scholar
• Rohde J, Jacobsen C, Kromann-Andersen H. Toxic hepatitis triggered by green tea. Ugeskr Laeger 2011;173(3):205-6
   PubMedGoogle Scholar
• Sarma DN, Barrett ML, Chavez ML, et al. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf 2008;31(6):469-84
   PubMed Web of Science ®Google Scholar
• Lambert JD, Kennett MJ, Sang S, et al. Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice. Food Chem Toxicol 2010;48:409-16
   PubMed Web of Science ®Google Scholar
• Weinstein DH, Twaddell WS, Raufman J-P, et al. SlimQuick™ - associated hepatotoxicity in a woman with alpha-1 antitrypsin heterozygosity. World J Hepatol 2012;4(4):154-7
   PubMedGoogle Scholar
• Fong TL, Klontz KC, Canas-Coto A, et al. Hepatotoxicity due to hydroxycut: a case series. Am J Gastroenterol 2010;105:1561-6
   PubMed Web of Science ®Google Scholar
• Wu KM, Yao J, Boring D. Green tea extract-induced lethal toxicity in fasted but not in nonfasted dogs. Int J Toxicol 2011;30(1):19-20
   PubMed Web of Science ®Google Scholar
• Barrette B. Medicinal properties of Echinacea: a critical review. Phytomedicine 2003;10:66-86
   PubMed Web of Science ®Google Scholar
• Toselli F, Matthais A, Gillam EMJ. Echinacea metabolism and drug interactions: the case for standardization of a complementary medicine. Life Sci 2009;85:97-106
   PubMed Web of Science ®Google Scholar
• Gorski JC, Huang S, Pinto A, et al. The effect of Echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 2004;75:89-100
   PubMed Web of Science ®Google Scholar
• Barnes J, Anderson LA, Gibbons S, Phillipson JD. Echinacea species (Echinacea angustifolia (DC.) Hell., Echinacea pallid (Nutt.) Nutt., Echinacea purpurea (L.) Moench): a review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol 2005;57:929-54
   PubMed Web of Science ®Google Scholar
• Wills RBH, Bone K, Morgan M. Herbal products: active constituents, modes of action and quality control. Nutr Res Rev 2000;13:47-77
   PubMed Web of Science ®Google Scholar
• Mukherjee PK, Ponnusankar S, Pandit S, et al. Botanicals as medicinal food and their effects on drug metabolizing enzymes. Food Chem Toxicol 2011;49:3142-53
   PubMed Web of Science ®Google Scholar
• Percival SS. Use of Echinacea in medicine. Biochem Pharmacol 2000;60:155-8
   PubMed Web of Science ®Google Scholar
• Goldhaber-Fiebert S, Kemper KJ. Echinacea (E. angustifolia, E. pallida, and E. purpurea). 1999. Avaliable from: www.longwoodherbal.org/echinacea/echinacea.pdf [Last accessed 30 March 2015]
   Google Scholar
• Miller LG. Herbal medicinals selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 1998;158:2200-11
   PubMed Web of Science ®Google Scholar
• Kocaman O, Hulagu S, Senturk O. Echinacea-induced severe acute hepatitis with features of cholestatic autoimmune hepatitis. EFIM 2008;19:148-52
   Web of Science ®Google Scholar
• Sarris J, LaPorte E, Schweitzer I. Kava: a comprehensive review of efficacy, safety, and psychopharmacology. Aust NZ J Psychiat 2011;45:27-35
   PubMed Web of Science ®Google Scholar
• Teschke R. Kava and the risk of liver toxicity: past, current, and future. 2011. Available from: www.ahpa.org/portals/0/pdfs/11_0303_March2011_AHPA_Report_Kava_Special_Report.pdf [Last accessed on 30 March 2015]
   Google Scholar
• Rouse J. Kava: a south pacific herb for anxiety, tension, and insomnia. Clin Nutr Insight 1998;6:1-2
   Google Scholar
• Humbertson CL, Akhtar J, Krenzelok EP. Acute hepatitis induced by kava kava. J Toxicol 2003;41:109-13
   Google Scholar
• Singh YN. Potential for interaction of kava and St John’s wort with drugs. J Ethnopharmacol 2005;100:108-13
   PubMed Web of Science ®Google Scholar
• Teschke R, Schwarzenboeck A, Akinci A. Kava hepatotoxicity: a european view. NZ Med J 2008;121:90-122
   PubMedGoogle Scholar
• Strahl S, Ehret V, Dahm HH, Maier KP. Necrotizing hepatitis after taking herbal remedies. Dtsch Med Wochenschr 1998;123:1410-14
   PubMed Web of Science ®Google Scholar
• Russmann S, Lauterburg BH, Helbling A. Kava hepatotoxicity. Ann Intern Med 2001;135:68-9
   PubMed Web of Science ®Google Scholar
• Escher M, Desmeules J, Giostra E, Mentha G. Hepatitis associated with Kava, a herbal remedy for anxiety. Br Med J 2001;322:139
   PubMed Web of Science ®Google Scholar
• Kraft M, Spahn TW, Menzel J, et al. Fulminant liver failure after administration of the herbal antidepressant Kava-Kava. Dtsch Med Wochenschr 2001;126:970-2
   PubMed Web of Science ®Google Scholar
• Christl SU, Seifert A, Seeler D. Toxic hepatitis after consumption of traditional Kava preparation. J Travel Med 2009;16:55-6
   PubMed Web of Science ®Google Scholar
• Ferguson AM, Garg U. Relatively safe herbal remedies. In: Dasgupta A, Hammmett-Stabler CA, editors. Herbal supplements: efficacy, toxicity, interactions, with western drugs, and effects on clinical laboratory tests. Wiley; New Jersey: 2011
   Google Scholar
• Yang S, Chen C, Li Y, et al. Saw palmetto extract enhances erectile responses by inhibition of phosphodiesterase 5 activity and increase in inducible nitric oxide synthase messenger ribonucleic acid expression in rat and rabbit corpus cavernosum. Urology 2013;81:1380.e7-e13
   PubMed Web of Science ®Google Scholar
• Singh YN, Devkota AK, Sneeden DC, et al. Hepatotoxicity of saw palmetto (Serenoa repens) in rats. Phytomedicine 2007;14:204-8
   PubMed Web of Science ®Google Scholar
• Penugonda K, Lindshield BL. Fatty acid and phytosterol content of commercial saw palmetto supplements. Nutrients 2013;5:3617-33
   PubMed Web of Science ®Google Scholar
• Wilt TJ, Ishani A, Stark G, et al. Saw palmetto extracts for treatment of benign prostatic hyperplasia: a systematic review. J Amer Med Assoc 1998;280:1604-9
   PubMed Web of Science ®Google Scholar
• Bent S, Kane C, Shinohara K, et al. Saw palmetto for benign prostate hyperplasia. New Engl J Med 2006;354:557-66
   PubMed Web of Science ®Google Scholar
• Avins AL, Bent S, Staccone S, et al. A detailed safety assessment of saw palmetto extract. Complement Ther Med 2008;16:147-54
   PubMed Web of Science ®Google Scholar
• Hamid S, Rojter S, Vierling J. Protracted cholestatic hepatitis after the use of Prostata. Ann Intern Med 1997;127:169-70
   PubMed Web of Science ®Google Scholar
• Lapi F, Gallo E, Glocallere E, et al. Acute liver damage due to Serenoa repens: a case report. Br J Clin Pharmacol 2010;69:558-60
   PubMed Web of Science ®Google Scholar
• Dave H, Ledwani L. A review on anthraquinones isolated from Cassia species and their applications. Indian J Nat Prod and Resour 2012;3:291-19
   Google Scholar
• Ulbricht C, Conquer J, Costa D, et al. An evidence-based systematic review of senna (Cassia senna) by the natural standard research collaboration. J Diet Suppl 2011;8:189-238
   PubMedGoogle Scholar
• Franz G. The senna drug and its chemistry. Pharmacol 1993;47(suppl 1):2-6
   PubMed Web of Science ®Google Scholar
• Shing S, Singh SK, Yadav A. A review on Cassia species: Pharmacology, traditional and medicinal aspects in various countries. AJPCT 2013;3:291-312
   Google Scholar
• Beuers U, Spengler U, Pape GR. Hepatitis after chronic use of senna. Lancet 1991;337:372-3
   PubMed Web of Science ®Google Scholar
• Vanderperren B, Rizzo M, Angenot L, et al. Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann Pharmacother 2005;39:1353-7
   PubMed Web of Science ®Google Scholar
• Soyuncu S, Cete Y, Nokay Portal vein thrombosis related to Cassia angustifolia. Clin Toxicol 2008;46:774-7
   PubMed Web of Science ®Google Scholar
• Li L, Bonneton F, Chen XY, Laudet V. Botanical compounds and their regulation of nuclear receptor action: The case of traditional Chinese medicine. Mol Cell Endocrinol 2015;401:221-37
   PubMed Web of Science ®Google Scholar
• Zhou SF, Xue CC, Yu XQ, Wang G. Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update. Curr Drug Metab 2007;8:526-53
   PubMed Web of Science ®Google Scholar
• Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol 2005;43:901-10
   PubMed Web of Science ®Google Scholar
• Lu YF, Wub Q, Liang SX, et al. Evaluation of hepatotoxicity potential of cinnabar-containing An-Gong-Niu-Huang Wan, a patent traditional Chinese medicine. Regul Tox Pharma 2011;60:206-11
   PubMed Web of Science ®Google Scholar
• Wang H, Bai J, Chen G, et al. A metabolic profiling analysis of the acute hepatotoxicity and nephrotoxicity of Zhusha Anshen Wan compared with cinnabar in rats using 1H NMR spectroscopy. J Ethnopharmacol 2013;146:572-80
   PubMed Web of Science ®Google Scholar
• Xue LM, Zhang QY, Han P, et al. Hepatotoxic constituents and toxicological mechanism of Xanthium strumarium L. fruits. J Ethnopharmacol 2014;152:272-82
   PubMed Web of Science ®Google Scholar
• Wu X, Chen X, Huang Q, et al. Toxicity of raw and processed roots of Polygonum multiflorum. Fitoterapia 2012;83:469-75
   PubMed Web of Science ®Google Scholar
• Yu J, Xie J, Mao X, et al. Hepatoxicity of major constituents and extractions of Radix polygoni multiflori and Radix polygoni multiflori praeparata. J Ethnopharmacol 2011;137:1291-9
   PubMed Web of Science ®Google Scholar
• Lei X, Chen J, Ren J, et al. Liver damage associated with Polygonum multiflorum Thunb.: A systematic review of case reports and case series. Evid-Based Compl Alt 2015;1-9
   Web of Science ®Google Scholar
• Hsu LM, Huang YS, Tsay SH, et al. Acute hepatitis induced by Chinese hepatoprotective herb, Xiao-Chai-Hu-Tang. JMCA 2006;69:86-8
   Google Scholar
• Houghton PJ. The scientific basis for the reputed activity of Valerian. J Pharm Pharmacol 1999;51(5):505-12
   PubMed Web of Science ®Google Scholar
• Taibi DM, Landis CA, Petry H, et al. A systematic review of valerian as a sleep aid: Safe but not effective. Sleep Med Rev 2007;11:209-30
   PubMed Web of Science ®Google Scholar
• Wheatly D. Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. J Psychopharmacol 2005;19:414-21
   PubMed Web of Science ®Google Scholar
• Patočka J, Jakl J. Biomedically relevant chemical constituents of Valeriana officinalis. J Appl Biomed 2010;8:11-18
   Web of Science ®Google Scholar
• Hadley S, Petry JJ. Valerian. Am Fam Physician 2003;67:1755-8
   PubMed Web of Science ®Google Scholar
• Taibi D, Vitiello M, Barsness S, et al. A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, andactigraphic sleep in older women with insomnia. Sleep Med Rev 2009;10(3):319-28
   Web of Science ®Google Scholar
• Fernandez-San-Martin MI, Masa-Font R, Palacios-Soler L, et al. Effectiveness of valerian on insomnia: A meta-analysis of randomized placebo-controlled trials. Sleep Med Rev 2010;11:505-11
   Web of Science ®Google Scholar
• Stevinson C, Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Med Rev 2000;1:91-9
   Web of Science ®Google Scholar
• Maroo N, Hazra A, Das T. Efficacy and safety of a polyphenol sedative-hypnotic formulation NSF-3 in a primary insomnia in comparison to zolpidem: Arandomized controlled trial. Indian J Pharmacol 2013;45:34-9
   PubMed Web of Science ®Google Scholar
• MacGregor FB, Abernethy VE, Dahabra S, et al. Hepatotoxicity of herbal remedies. Br Med J 1989;299:1156-7
   PubMed Web of Science ®Google Scholar
• Cohen DL, Del Toro Y. A case of valerian associated hepatotoxicity. J Clin Gastroenterol 2008;42:961-2
   PubMed Web of Science ®Google Scholar
• Whiting PW, Clouston A, Kerlin P. Black cohosh and other herbal remedies associated with acute hepatitis. MJA 2002;177:440-3
   PubMed Web of Science ®Google Scholar
• Williams CA, Lamprecht ED. Some commonly fed herbs and other functional foods in equine nutrition: a review. Vet J 2008;178:21-31
   PubMed Web of Science ®Google Scholar
• Vassiliadis T, Anagnostis P, Patsiaoura K, et al. Valeriana hepatotoxicity. Sleep Med 2009;10:935-6
   PubMed Web of Science ®Google Scholar
• Chan TYK, Tang CH, Crichley JAJH. Poisoning due to an over the counter hypnotic, Sleep-Qik (hycosine, cyproheptadine, valerian). Postgrad Med J 1995;71:227-8
   PubMed Web of Science ®Google Scholar
• Vo LT, Chan D, King RG. Investigation of the effects of peppermint oil and valerian on rat liver and cultured human liver cells. Clin Exp Pharmacol Physiol 2003;30:799-804
   PubMed Web of Science ®Google Scholar
• Oran S. Check-list of medicinal plants in Jordan. Dirasat 1998;25:84-112
   Google Scholar
• Larrey D, Vial T, Pauwels A, et al. Hepatitis after Germander (Teucrium chamaedrys) administration: Another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992;117(2):129-32
   PubMed Web of Science ®Google Scholar
• Gori L, Galluzzi P, Mascherini V, et al. Two contemporary cases of hepatitis associated with Teucrium chamaedrys L. decoction use. Case reports and review of literature. Basic Clin Pharmacol Toxicol 2011;109:521-6
   PubMed Web of Science ®Google Scholar
• Mostefa-Kara N, Pauwels A, Pines E, et al. Fatal hepatitis after herbal tea. Lancet 1992;340:674
   PubMed Web of Science ®Google Scholar
• Pacifico S, D’Abrosca B, Pascarella MT, et al. Antioxidant efficacy of iridoid and phenylethanoid glycosides from the medicinal plant Teucrium chamaedrys in cell free systems. Bioorg Med Chem 2009;17:6173-9
   PubMed Web of Science ®Google Scholar
• Piozzi F, Rodriguez B, Savona G. Advances in the chemistry of the furano- diterpenoids from Teucrium species. Heterocycles 1987;25:807-41
   Web of Science ®Google Scholar
• Fau D, Lekehal M, Farrell G, et al. Diterpenoids from Germander, an herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology 1997;113:1334-46
   PubMed Web of Science ®Google Scholar
• Lekehal M, Pessayre D, Lereau JM, et al. Hepatotoxicity of the herbal medicine Germander: metabolic activation of its furano diterpenoids by cytochrome P450 3A depletes cytoskeleton associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology 1996;24:212-18
   PubMed Web of Science ®Google Scholar
• Loeper J, De Berardinis V, Moulis C, et al. Human epoxide hydrolase is the target of Germander autoantibodies on the surface of human hepatocytes: enzymatic implications. Adv Exp Med Biol 2001;500:121-4
   PubMed Web of Science ®Google Scholar
• Teschke R, Frenzel C, Glass X, et al. Herbal hepatotoxicity: a critical review. Br J Clin Pharmacol 2012;75(3):630-6
   Web of Science ®Google Scholar